Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan R Wall

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Biochimica Et Biophysica Acta. Reviews on Cancer|July 10, 2024
Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potentialRyan N Fuller, Ann Morcos, Joab Galvan Bustillos, et al.
Cancers|June 26, 2026
Extracellular Vesicles in Diffuse Midline Glioma: Emerging Mediators of Radiation Response and Therapeutic ResistanceAnn Morcos, Yeonkyu Jung, Ryan N Fuller, et al.
Frontiers in Genetics|June 26, 2024
miRNA signatures underlie chemoresistance in the gemcitabine-resistant pancreatic ductal adenocarcinoma cell line MIA PaCa-2 GRRyan N Fuller, Paul A Vallejos, Janviere Kabagwira, et al.
Cancer Letters|June 25, 2013
Clinico-pathologic relevance of Survivin splice variant expression in cancerRosalia de Necochea-Campion, Chien-Shing Chen, Saied Mirshahidi, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|April 1, 2018
Peripheral Blood Cell Interactions of Cancer-Derived Exosomes Affect Immune FunctionHeather R Ferguson Bennit, Amber Gonda, James R W McMullen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesisOlivier P Blanc-Brude, Mehdi Mesri, Nathan R Wall, et al.
BMC Cancer|March 14, 2014
Early diagnostic value of survivin and its alternative splice variants in breast cancerSalma Khan, Heather Ferguson Bennit, David Turay, et al.
Blood and Lymphatic Cancer : Targets and Therapy|July 31, 2019
Uptake of lymphoma-derived exosomes by peripheral blood leukocytesHeather R Ferguson Bennit, Amber Gonda, Laura J Oppegard, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 19, 2010
Survivin is released from cancer cells via exosomesSalma Khan, Jessica M S Jutzy, Jonathan R Aspe, et al.
Journal of Extracellular Vesicles|March 14, 2014
Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutantJonathan R Aspe, Carlos J Diaz Osterman, Jessica M S Jutzy, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Biochimica Et Biophysica Acta. Reviews on Cancer|July 10, 2024
Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potentialRyan N Fuller, Ann Morcos, Joab Galvan Bustillos, et al.
Cancers|June 26, 2026
Extracellular Vesicles in Diffuse Midline Glioma: Emerging Mediators of Radiation Response and Therapeutic ResistanceAnn Morcos, Yeonkyu Jung, Ryan N Fuller, et al.
Frontiers in Genetics|June 26, 2024
miRNA signatures underlie chemoresistance in the gemcitabine-resistant pancreatic ductal adenocarcinoma cell line MIA PaCa-2 GRRyan N Fuller, Paul A Vallejos, Janviere Kabagwira, et al.
Cancer Letters|June 25, 2013
Clinico-pathologic relevance of Survivin splice variant expression in cancerRosalia de Necochea-Campion, Chien-Shing Chen, Saied Mirshahidi, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|April 1, 2018
Peripheral Blood Cell Interactions of Cancer-Derived Exosomes Affect Immune FunctionHeather R Ferguson Bennit, Amber Gonda, James R W McMullen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesisOlivier P Blanc-Brude, Mehdi Mesri, Nathan R Wall, et al.
BMC Cancer|March 14, 2014
Early diagnostic value of survivin and its alternative splice variants in breast cancerSalma Khan, Heather Ferguson Bennit, David Turay, et al.
Blood and Lymphatic Cancer : Targets and Therapy|July 31, 2019
Uptake of lymphoma-derived exosomes by peripheral blood leukocytesHeather R Ferguson Bennit, Amber Gonda, Laura J Oppegard, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 19, 2010
Survivin is released from cancer cells via exosomesSalma Khan, Jessica M S Jutzy, Jonathan R Aspe, et al.
Journal of Extracellular Vesicles|March 14, 2014
Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutantJonathan R Aspe, Carlos J Diaz Osterman, Jessica M S Jutzy, et al.
Pageof 7